Does CIRM discourage development of CIRM-Funded Technology through Non-Exclusive Licenses?
No. In fact, CIRM encourages broad sharing of CIRM-Funded Research. In the context of licensing arrangements, CIRM encourages development by Grantees via Non-Exclusive Licenses. CIRM believes Non-Exclusive Licenses have the greatest potential in many cases to further develop the scientific field and ensure the broadest benefit across all disease-related research. If a Grantee elects not to self-develop the fruits of its CIRM-Funded Research and instead determines licensing the technology is the best path forward, the Grantee must make commercially reasonable efforts to negotiate Non-Exclusive Licenses, unless it would put a Grantee at a disadvantage with a competitor or if necessary to provide economic incentive to commercialize invention.